Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML.

Source:http://linkedlifedata.com/resource/pubmed/id/16410449

Blood 2006 May 1 107 9 3700-7

Download in:

View as

General Info

PMID
16410449